Cynthia M. Rominger - Concepedia

Concepedia

Author

Cynthia M. Rominger

GlaxoSmithKline (United States)

Also Known As

C. Rominger, Cynthia M. Rominger, Cynthia Rominger

38

Publications

1.8K

Citations

15

H-Index

29

Concepts

All Affiliations

GlaxoSmithKline (United States)South College Bristol-Myers Squibb (United States)Wilmington University Research Triangle Park Foundation

CM

About

Cynthia M. Rominger is an author at GlaxoSmithKline (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	635
2	Natural Sciences	5	5	170
3	Biochemistry	5	5	170
4	Cell Biology	2	2	284
5	Cellular Physiology	1	1	22

Cynthia M. Rominger

×

15

Publications

1.8K

Citations

15

H-Index

	Year	Citations
GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained <i>In Vivo</i> Pathway Inhibition Aidan G. Gilmartin, Maureen R. Bleam, Arthur Groy, Clinical Cancer Research	2011	590
Presenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors Dietmar Seiffert, Jodi D. Bradley, Cynthia M. Rominger, Journal of Biological Chemistry	2000	301
Demonstration of a Genetic Therapeutic Index for Tumors Expressing Oncogenic <i>BRAF</i> by the Kinase Inhibitor SB-590885 Alastair J. King, Denis R. Patrick, Roberta S. Batorsky, Cancer Research PathologyOncogenic Braf AllelesTumor BiologyOncologyTumor Phenotype	2006	262
New IDH1 mutant inhibitors for treatment of acute myeloid leukemia Ujunwa Cynthia Okoye-Okafor, Boris Bartholdy, Jessy Cartier, Nature Chemical Biology Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaPharmacology	2015	174
Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors Lin Hong, Jin Zeng, Ren Xie, ACS Medicinal Chemistry Letters	2015	84
Characterization of [125I]Sauvagine Binding to CRH2 Receptors: Membrane Homogenate and Autoradiographic Studies David H. Rominger, Cynthia M. Rominger, Lawrence W. Fitzgerald, Journal of Pharmacology and Experimental Therapeutics	1998	65
Evidence for Allosteric Interactions of Antagonist Binding to the Smoothened Receptor Cynthia M. Rominger, Weilin Tiger Bee, Robert A. Copeland, Journal of Pharmacology and Experimental Therapeutics	2009	63
Synthesis and structure–activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent β isoform selective phosphatidylinositol 3-kinase inhibitors Robert M. Sanchez, Karl F. Erhard, Mary Ann Hardwicke, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryNovel SeriesBiochemistryMedicine	2012	53
Synthesis and structure–activity relationships of imidazo[1,2-a]pyrimidin-5(1H)-ones as a novel series of beta isoform selective phosphatidylinositol 3-kinase inhibitors Hong Lin, Karl F. Erhard, Mary Ann Hardwicke, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryNovel SeriesBiochemistryNatural Sciences	2012	41
Binding Sites of γ-Secretase Inhibitors in Rodent Brain: Distribution, Postnatal Development, and Effect of Deafferentation Xiao-Xin Yan, Tong Li, Cynthia M. Rominger, Journal of Neuroscience	2004	41

Page 1